These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 35646115)
1. Downregulation of hsa-miR-30b-3p Inhibits the Oncogenicity of Lung Adenocarcinoma by Targeting the Li N; Li R; Song B; Ge H; Qu Y J Oncol; 2022; 2022():6883140. PubMed ID: 35646115 [TBL] [Abstract][Full Text] [Related]
2. [miR-30b-3p Inhibits the Proliferation and Invasion of Lung Adenocarcinoma by Targeting COX6B1]. Chen L; Chen X; Liu L; Zhao Y; Zuo W; Yin C; Li H Zhongguo Fei Ai Za Zhi; 2022 Aug; 25(8):567-574. PubMed ID: 36002193 [TBL] [Abstract][Full Text] [Related]
3. The clinical significance and mechanism of microRNA-22-3p targeting TP53 in lung adenocarcinoma. Lin R; Li GS; Gan XY; Peng JX; Feng Y; Wang LT; Zhang CY; Huang KY; Huang SH; Yang L; Kong JL; Zhou HF; Chen G; Huang WY Technol Health Care; 2023; 31(5):1691-1707. PubMed ID: 36970920 [TBL] [Abstract][Full Text] [Related]
4. Circ-AASDH functions as the progression of early stage lung adenocarcinoma by targeting miR-140-3p to activate E2F7 expression. Wang Y; Wo Y; Lu T; Sun X; Liu A; Dong Y; Du W; Su W; Huang Z; Jiao W Transl Lung Cancer Res; 2021 Jan; 10(1):57-70. PubMed ID: 33569293 [TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA FAM83A antisense RNA 1 (lncRNA FAM83A-AS1) targets microRNA-141-3p to regulate lung adenocarcinoma cell proliferation, migration, invasion, and epithelial-mesenchymal transition progression. Huang H; Yang C; Zhang Q; Zhuo T; Li X; Li N; Zhu L; Luo C; Gan J; Wu Y Bioengineered; 2022 Mar; 13(3):4964-4977. PubMed ID: 35164653 [TBL] [Abstract][Full Text] [Related]
6. MiR-202-3p inhibits the proliferation and metastasis of lung adenocarcinoma cells by targeting RRM2. Cao X; Xue F; Chen H; Shen L; Yuan X; Yu Y; Zong Y; Zhong L; Huang F Ann Transl Med; 2022 Dec; 10(24):1374. PubMed ID: 36660663 [TBL] [Abstract][Full Text] [Related]
7. Knockdown of lncRNA LINC00662 suppresses malignant behaviour of osteosarcoma cells via competition with miR-30b-3p to regulate ELK1 expression. Wang B; Xu Z; Wang X; Xia S; Cai P; Wang M; Gao Z J Orthop Surg Res; 2022 Feb; 17(1):74. PubMed ID: 35123530 [TBL] [Abstract][Full Text] [Related]
8. MiR-490-3p Inhibits the Malignant Progression of Lung Adenocarcinoma. Li Z; Jiang D; Yang S Cancer Manag Res; 2020; 12():10975-10984. PubMed ID: 33154676 [TBL] [Abstract][Full Text] [Related]
9. Prognosis Value of microRNA-3677-3p in Lung Adenocarcinoma and Its Regulatory Effect on Tumor Progression. Zhao J; Yu H; Han T; Zhu X Cancer Manag Res; 2021; 13():9261-9270. PubMed ID: 34955656 [TBL] [Abstract][Full Text] [Related]
10. CircPRKCI regulates proliferation, migration and cycle of lung adenocarcinoma cells by targeting miR-219a-5p-regulated CAMK1D. Sui MH; Zhang WW; Geng DM; Sun DJ Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1899-1909. PubMed ID: 33660800 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic and prognostic value of microRNA-2355-3p and contribution to the progression in lung adenocarcinoma. Zhao Y; Zhang W; Yang Y; Dai E; Bai Y Bioengineered; 2021 Dec; 12(1):4747-4756. PubMed ID: 34334103 [TBL] [Abstract][Full Text] [Related]
12. LINC00346 Sponges miR-30c-2-3p to Promote the Development of Lung Adenocarcinoma by Targeting MYBL2 and Regulating CELL CYCLE Signaling Pathway. Xu Q; Xu Z; Zhu K; Lin J; Ye B Front Oncol; 2021; 11():687208. PubMed ID: 34631522 [TBL] [Abstract][Full Text] [Related]
13. MiR-340-3p-HUS1 axis suppresses proliferation and migration in lung adenocarcinoma cells. Ren K; Yu Y; Wang X; Liu H; Zhao J Life Sci; 2021 Jun; 274():119330. PubMed ID: 33711383 [TBL] [Abstract][Full Text] [Related]
14. Mir-30b-3p affects the migration and invasion function of ovarian cancer cells by targeting the CTHRC1 gene. Li Y; Zhou J; Wang J; Chen X; Zhu Y; Chen Y Biol Res; 2020 Mar; 53(1):10. PubMed ID: 32156314 [TBL] [Abstract][Full Text] [Related]
15. METTL7B (methyltransferase-like 7B) identification as a novel biomarker for lung adenocarcinoma. Ali J; Liu W; Duan W; Liu C; Song J; Ali S; Li E; Wang Q Ann Transl Med; 2020 Sep; 8(18):1130. PubMed ID: 33240979 [TBL] [Abstract][Full Text] [Related]
16. METTL7B serves as a prognostic biomarker and promotes metastasis of lung adenocarcinoma cells. Li R; Mu C; Cao Y; Fan Y Ann Transl Med; 2022 Aug; 10(16):895. PubMed ID: 36110989 [TBL] [Abstract][Full Text] [Related]
18. LncRNA DGCR5 promotes lung adenocarcinoma (LUAD) progression via inhibiting hsa-mir-22-3p. Dong HX; Wang R; Jin XY; Zeng J; Pan J J Cell Physiol; 2018 May; 233(5):4126-4136. PubMed ID: 29030962 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-140-3p represses the proliferation, migration, invasion and angiogenesis of lung adenocarcinoma cells via targeting TYMS (thymidylate synthetase). Wan S; Liu Z; Chen Y; Mai Z; Jiang M; Di Q; Sun B Bioengineered; 2021 Dec; 12(2):11959-11977. PubMed ID: 34818974 [TBL] [Abstract][Full Text] [Related]
20. circ_0000567/miR-421/ Hong Y; Si J; Xiao B; Xiong Y; Dai C; Yang Y; Li S; Ma Y J Cancer; 2022; 13(5):1540-1552. PubMed ID: 35371319 [No Abstract] [Full Text] [Related] [Next] [New Search]